Abstract
Background/SignificanceSleep apnea (SA) is associated with hypertension and chronic kidney disease. Changes in adenosine signaling associated with chronic intermittent hypoxia (CIH) during apneic episodes may alter glomerular hemodynamics and contribute to hyperfiltration. In addition, increased signaling through the adenosine type 2B receptor (A2B) may promote inflammation and contribute to renal damage and eventual declines in renal function.HypothesisWe hypothesized that short‐term exposure to CIH would promote increased glomerular filtration rate and upregulation of A2B, IL‐6, NGAL, and α‐smooth muscle actin (SMA) expression in the kidney.MethodsAdult male Sprague Dawley rats were exposed to 10 days CIH (60 sec. FiO2 10%, 120 sec. FiO2 21%) for 8h/d. Glomerular filtration rate (GFR) was measured transdermally (Medibeacon) pre‐ and post‐CIH, and post‐CIH (or sham) renal blood flow (RBF) was measured using Transonic flow probes (2% isoflurane, FiO2 21% and 10%). Cortical and medullary expression of A2B, IL‐6, NGAL, and α‐smooth muscle actin (SMA) was measured via western blot.ResultsWeight‐corrected RBF decreased modestly (15%) after 10 days of CIH (1.89±0.13 mL/min/g vs. 1.42±0.16 mL/min/g, p<0.05). In contrast weight‐corrected GFR increased by 80% from pre‐ to post‐CIH measurements (3.1±0.27 mL/min/g vs. 5.5±0.51 mL/min/g, p<0.05). Renal cortical A2B (1.0±0.09 sham vs. 1.42±0.15 CIH, p<0.05) and IL‐6 (1.0±0.11 sham vs. 1.56±0.21 CIH, p<0.05) and medullary NGAL (1.0±0.22 sham vs. 2.68±0.65 CIH, p<0.05) expression was increased in CIH relative to sham tissue. SMA was not significantly different between groups.ConclusionsIntermittent hypoxia induces glomerular hyperfiltration and upregulation of renal A2B/pro‐inflammatory pathways, which in turn may precede renal injury.Support or Funding InformationSupported by a grant from NHLBI (R15 HL138600‐01 to NJM)This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.